Fractyl Health Overview
Valuation check: GUTS's ROE is 6345.35%, above the sector sector average of -5.68%.
Get informed when a big investor buys or sells
+ Follow6345.35%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Fractyl Health (GUTS) currently reports a ROE of 6345.35%. That is above the sector sector average of -5.68%. Use the charts on this page to explore Fractyl Health's ROE history and peer comparisons.
Fractyl Health's ROE of 6345.35% is higher than the its sector sector average of -5.68%. That is roughly 111751.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Fractyl Health's current 6345.35% should be judged against industry norms (sector average: -5.68%) and against GUTS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 6345.35%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -5.68%. From there, open related valuation or income-statement pages for Fractyl Health, and consider following GUTS for alerts when major investors trade the stock.
